NexGold Intersects 3.31 g/t Gold over 20.0 Metres at the Goldlund Deposit, and Announces Change in Board of Directors

(TSX-V:NEXG),(OTC US:NXGCF),(Other OTC:NXGCF), TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to provide initial results from the recently announced diamond drilling program (Company news release dated January 28, 2026), which comprises up to 25,000 metres at the Goliath Gold Complex (comprised of the […]

Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne

(NasdaqGM:SGMT), SAN MATEO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis Pharma Inc. issued a press release on January 29th reporting positive topline results in the open-label Phase 3 trial evaluating the long-term safety

Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics

(OTCQB:BIXT),(OTC US:BIXT), NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) — Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, announced the execution of a Sponsored Research Agreement with the University of Minnesota to support advanced biochemical research aimed at improving the understanding and

TTM Technologies, Inc. Appoints Two New Independent Directors

(NASDAQ:TTMI),(NYSE:DCO),(NASDAQ:WWD),(NYSE:CACI), SANTA ANA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, and technologically advanced interconnect solutions, including printed circuit boards (“PCB”) and substrates, today announced that, after long and distinguished careers with TTM,

Trident Announces Full Exercise of Over-Allotment Option and Expected Proceeds of $18.6 Million to Fully Fund Expanded 2026 Drilling at Saskatchewan Gold Projects

(TSX-V:ROCK),(OTC US:TRDTF),(Other OTC:TRDTF), Vancouver, BC, Feb. 02, 2026 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company“) is pleased to announce that, in connection with its previously announced bought deal financing (the “Bought Deal Offering“), the underwriters led by Haywood Securities Inc., and including Research Capital Corporation (collectively, the “Underwriters“),

Nova Leap Health Corp. Launches Palliative Care Division In Nova Scotia Through Earth Angels Home Care

(TSX-V:NLH),(OTC US:NVLPF),(Other OTC:NVLPF), NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Feb. 02, 2026 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a provider of home-based and community-based healthcare services across North America, today announced the launch of a dedicated

Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm(TM)

(NasdaqGM:AQST), Deficiencies limited to packaging and administration Company believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026 Remains well-capitalized and anticipates ending 2026 with significant cash Reiterates plans to submit in Canada and EU by the end of 2026 Company to host investor call on February 2, 2026, at

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270-$280 Million, Marking Another Year of Strong Growth

(NasdaqGM:HROW), Doubling of VEVYE(R) Sales Force is On Track, Expansion of IHEEZO(R) Commercial Footprint to the Office-Based Setting Underway, and Doubling TRIESENCE(R) Commercial Footprint in the Surgical-Based Setting is Proceeding OneHarrow Initiative is Launched to Unify Branding under Harrow Patrick W. Sullivan Promoted to Serve as Harrow's Chief Commercial Officer MELT-300 and MELT-210 Programs on

AmpliTech Group Lists Series A & B Rights on Nasdaq

(NASDAQ:AMPG),(NASDAQ:AMPGW), HAUPPAUGE, N.Y., Feb. 02, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW, AMPGR, AMPGZ) today announced the approval of the Company's listing of its Series A and Series B Rights on the Nasdaq Capital Market. It is anticipated that the Series A and B Rights will begin trading on February 3, 2026,

SDG receives US Air Force Air Mobility Command T-1 certification for RO/RO TRASC capability for C-130 variants

(NASDAQ:GOGO), SINGAPORE, Feb. 02, 2026 (GLOBE NEWSWIRE) — SD Government, (SDG) the division of Gogo (NASDAQ: GOGO) providing satellite communications to global governments, has received US Air Force Air Mobility Command (AMC) T-1 certification for the Roll-on/Roll-off (RO/RO) Beyond Line of Sight (BLOS) Tactical Removeable Airborne Satellite Communications (TRASC) capability for C-130 aircraft. The T-1

Scroll to Top